Delirium, Dementia, Amnestic, Cognitive Disorders  >>  bapineuzumab (AAB-001)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bapineuzumab (AAB-001) / Pfizer, J&J, Perrigo Company
NCT00397891: Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Completed
1
80
Japan
bapineuzumab
Wyeth is now a wholly owned subsidiary of Pfizer
Alzheimer Disease
02/10
02/10

Download Options